For: | Feng R, Cheng DX, Chen XC, Yang L, Wu H. Application of sintilimab combined with anlotinib hydrochloride in the clinical treatment of microsatellite stable colorectal cancer. World J Gastrointest Oncol 2023; 15(11): 1925-1935 [PMID: 38077647 DOI: 10.4251/wjgo.v15.i11.1925] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v15/i11/1925.htm |
Number | Citing Articles |
1 |
Mateusz Kciuk, Katarzyna Wanke, Weronika Kruczkowska, Beata Marciniak, Renata Kontek. Focus on PD-1/PD-L1-Targeting Antibodies in Colorectal Cancer: Are There Options Beyond Dostarlimab, Nivolumab, and Pembrolizumab? A Comprehensive Review. Molecules 2025; 30(13): 2686 doi: 10.3390/molecules30132686
|